Journals / Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 16 - Sayı: 3

HOMOCYSTEIN PHOLIC ACID AND VIT B12 LEVELS IN RECURRENT PREGNANCY LOSSES

Habituel Abortus Olan Gebelerde Homosistein Folik Asid ve Vit B12 Seviyelerinin Değerlendirilmesi

Pages
417–420
Publication Date
2021-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We think that homocysteine, vitamin B12 and folic acid levels are important factors in ethiology in patients with recurrent pregnancy loss.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:HOMOCYSTEIN PHOLIC ACID AND VIT B12 LEVELS IN RECURRENT PREGNANCY LOSSES Summary; Recurrent pregnancy loss is defined as two or more unsuccessful clinical pregnancies or three consecutive pregnancies that are not necessarily intrauterine (3).
📊
Key Findings & Data:There are studies showing that homocysteine levels increase or do not change in recurrent pregnancy losses.
💡
Conclusion & Impact:Conclusion: We think that homocysteine, vitamin B12 and folic acid levels are important factors in ethiology in patients with recurrent pregnancy loss.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:tekrarlayan gebelik kaybı · folik asit · homosistein

Abstract

HOMOCYSTEIN PHOLIC ACID AND VIT B12 LEVELS IN RECURRENT PREGNANCY LOSSES Summary; Recurrent pregnancy loss is defined as two or more unsuccessful clinical pregnancies or three consecutive pregnancies that are not necessarily intrauterine (3). There are studies showing that homocysteine levels increase or do not change in recurrent pregnancy losses. In this study, it was aimed whether there was a change in B12 and folic acid levels, which have important functions in the excretion of free radical-like homocysteine and homocysteine in recurrent pregnancy losses. Materials and Methods: This study included 30 patients with recurrent pregnancy loss (Group I) and 1. Plasma homocysteine, serum folic acid and vitamin B12 levels were evaluated in 30 healthy pregnant women (Group II) in the trimester without any complaints. Results: Homocysteine levels (µmol / L), Group I: 17.6 ± 9.5, Group II: 11.8 ± 4.6, Vitamin B12 levels (ng / L): Group I: 233.4 ± 69, 5, Group II: 262.4 ± 76.7, folic acid levels (µg / L): Group I: 7.7 ± 3.3, Group II: 11.3 ± 3.7. At homocysteine levels; A statistically significant increase was found in the group with recurrent pregnancy loss (Group I) (p <0.05). At folic acid levels; A statistically significant decrease was found in the group with recurrent pregnancy loss (Group I) (p <0.05). There was no statistically significant difference in vitamin B12 levels between the groups (p = .0.186). There was no statistically significant difference between ages (p = 0.210). Conclusion: We think that homocysteine, vitamin B12 and folic acid levels are important factors in ethiology in patients with recurrent pregnancy loss.

Özet

Tekrarlayan gebelik kaybı iki veya daha fazla başarısız klinik gebelik veya intrauterin olması gerekmeyen ardışık üç gebelik kaybı olarak tanımlanır(3). Tekrarlayan gebelik kayıplarında homosistein düzeylerinin arttığını yada değişmediğini gösteren çalışmalar mevcuttur. Bu çalışmada, tekrarlayan gebelik kayıplarında serbest radikal benzeri etki gösteren homosistein ve homosisitein’in atılımında önemli fonksiyonlara sahip olan B12 ve folik asit düzeylerinde değişim olup olmadığı amaçlandı. Gereç ve Yöntem: Bu çalışma, Kahramanmaraş Necip Fazıl Şehir Hastanesi Kadın Doğum ve Çocuk Hastalıkları ek binasında, retrospektif olarak ocak ve aralık 2020 tarihleri arasında 1. trimester tekrarlayan gebelik kaybı nedeniyle başvuran, 30 tekrarlayan gebelik kaybı olan hasta (Grup I) ve 1. trimesterde bulunan herhangi bir şikayeti olmayan 30 sağlıklı gebede (Grup II) plazma homosistein, serum folik asit ve vitamin B12 düzeyleri değerlendirildi. Bulgular: Homosistein düzeyleri (µmol/L), Grup I: 17,6 ± 9,5, Grup II: 11,8 ± 4,6, Vitamin B12 düzeyleri (ng/L): Grup I: 233,4 ± 69,5, Grup II: 262,4 ± 76,7, folik asit düzeyleri (µg/L): Grup I: 7,7 ± 3,3, Grup II: 11,3 ± 3,7 olarak saptandı. Homosistein düzeylerinde; tekrarlayan gebelik kaybı olan grupta (Grup I) istatistiksel olarak anlamlı yükseklik saptandı (p<0.05). Folik asit düzeylerinde; tekrarlayan gebelik kaybı olan grupta (Grup I) istatistiksel olarak anlamlı düşüklük bulundu (p<0.05). Vitamin B12 düzeylerinde gruplar arasında istatistiksel olarak anlamlı bir fark görülmedi (p=.0.186). Yaşlar arasında istatistiksel olarak anlamlı bir fark saptanmadı (p=0.210). Sonuç: Tekrarlayan gebelik kaybı olan hastalarda, homosistein, vitamin B12, folik asit düzeylerinin ethiolojide önemli bir etken olduğunu düşünmekteyiz

🔖

Cite This Article

ÇIKIM, G., TOK, A. (2021). HOMOCYSTEIN PHOLIC ACID AND VIT B12 LEVELS IN RECURRENT PREGNANCY LOSSES. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, Cilt: 16 - Sayı: 3, 417–420. https://ajindex.com/articles/783206

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. American College of Obstetricans and Gynecologists. Management of recurrent early pregnancy loss. ACOG Practice Bulletin 2001
  2. 1–8. 2. Hee Young Cho, Han Sung Park, Eun Ju Ko, Chang Soo Ryu, Jung Oh Kim, Young Ran, Eun Hee Ahn, Woo Sik, Nam Keun Kim. Association of Complement Factor D and H Polymorphisms with Recurrent Pregnancy LossInt J. Mol. Sci. 2020, 21-17. 3. Fateme Aghajanzadeh, Sedighe Esmaeilzadeh, Zahra Basirat, Treza Mahouti, Fateme Nadi Heidari, Masoumeh Golsorkhtabaramiri. Using autologous intrauterine platelet-rich plasma to improve the reproductive outcomes of women with recurrent implantation failure JBRA Assisted Reproduction 2020
  3. 24(1):30-33. 4. Avisek Majumder, Mahavir Singh, Akash George, Suresh Tyagi. Restoration of skeletal muscle homeostasis by hydrogen sulfide during hyperhomocysteinemia-mediated oxidative/ER stress condition Can J Physiol Pharmacol. 2019 June
  4. 97(6): 441–456. 5. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease Nutr J. 2015 Jan 10
  5. Perna AF, Ingrosso D. Homocysteine and chronic kidney disease: an ongoing narrative. J Nephrol. 2019 Oct
  6. 32(5):673-675. 7. Gaiday AN, Tussupkaliyev AB, Bermagambetova SK, Zhumagulova SS, Sarsembayeva LK, Dossimbetova MB, et al. Effect of homocysteine on pregnancy: a systematic review. Chem Biol Interact 2018
  7. 70–6. 8. Foka ZJ, Lambropoulos AF. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.Hum Reprod, 2000
  8. 458–62. 9. Romine MF, Rodionov DA, Maezato Y, Anderson LN, Nandhikonda P, Rodionova IA, et al. Elucidation of roles for vitamin B12 in regulation of folate, ubiquinone, and methionine metabolism. Proceedings of the National Academy of Sciences. 2017
  9. 114 (7). 10. Kalem P, Benli AR, Koroglu M, Benli NC, Koyuncu M, Cesur O, et al. The effect of ferritin, vitamin B12 and folic acid on pregnancy outcomes. Int J Clin Exp Med. 2016
  10. 9(11):22413-7. 11. Garcia-Casal M, Osorio C, Landaeta M, Leets I, Matus P, Fazzino F, et al. High prevalence of folic acid and vitamin B12 deficiencies infants, children, adolescents and pregnant women in Venezuela. European Journal of Clinical Nutrition. 2005
  11. 59(9):1064-70. 12. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomised placebo controlled trial. BMJ. 2010
  12. c2181. 13. Lam JR, Schneider JL, Zhao W, Corley